In an earnings call last week CVS Health CEO Larry Merlo outlined some of the ways that the company is moving forward on plans to reduce medical costs after its $69 billion purchase of Aetna.
Regulatory approval for the purchase is predicated on Aetna's previously announced plans to sell off its Medicare Part D business to WellCare Health.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.